Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sudipta Sonar"'
Autor:
Rajat Ujjainiya, Akansha Tyagi, Viren Sardana, Salwa Naushin, Nitin Bhatheja, Kartik Kumar, Joydeb Barman, Satyartha Prakash, Rintu Kutum, Akash Kumar Bhaskar, Prateek Singh, Kumardeep Chaudhary, Menka Loomba, Yukti Khanna, Chestha Walecha, Rizwan Ahmed, Ashutosh Yadav, Archana Bajaj, Gaurav Malik, Sahar Qureshi, Swati Waghdhare, Samreen Siddiqui, Kamal Krishan Trehan, Manju Mani, Rajiv Dang, Poonam Das, Pankaj Dougall, Monica Mahajan, Sudipta Sonar, Kamini Jakhar, Reema Kumar, Mahima Tiwari, Shailendra Mani, Sankar Bhattacharyya, Sandeep Budhiraja, Anurag Agrawal, Debasis Dash, Sujeet Jha, Shantanu Sengupta
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-6 (2022)
The authors study a cohort of healthcare workers in India who received two doses of the ChAdOx-1-nCoV19 vaccine during the Delta wave. Using serological data, they infer that 25% of the cohort were infected within 60 days of vaccination, although the
Externí odkaz:
https://doaj.org/article/9a70c4390c7c488d884e0948bcbafd44
Autor:
Hilal Ahmad Parray, Naveen Narayanan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh K Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Sanjeev Kumar, Kamini Jakhar, Sudipta Sonar, Anil Kumar Panchal, Manas Ranjan Tripathy, Shirlie Roy Chowdhury, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Kalpana Luthra, Gaurav Batra, Devinder Sehgal, Guruprasad R Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Kumar Garg, Deepak T Nair, Rajesh Kumar
Publikováno v:
PLoS Pathogens, Vol 18, Iss 12, p e1010994 (2022)
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic monoclonal antibodies (mAbs). Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concern (V
Externí odkaz:
https://doaj.org/article/3ba087963a9548d5823331f44d97566f
Autor:
Nitin Hingankar, Suprit Deshpande, Payel Das, Zaigham Abbas Rizvi, Constantinos Kurt Wibmer, Poppy Mashilo, Mohammed Yousuf Ansari, Alison Burns, Shawn Barman, Fangzhu Zhao, Sohini Mukherjee, Jonathan L Torres, Souvick Chattopadhyay, Farha Mehdi, Jyoti Sutar, Deepak Kumar Rathore, Kamal Pargai, Janmejay Singh, Sudipta Sonar, Kamini Jakhar, Jyotsna Dandotiya, Sankar Bhattacharyya, Shailendra Mani, Sweety Samal, Savita Singh, Pallavi Kshetrapal, Ramachandran Thiruvengadam, Gaurav Batra, Guruprasad Medigeshi, Andrew B Ward, Shinjini Bhatnagar, Amit Awasthi, Devin Sok, Jayanta Bhattacharya
Publikováno v:
PLoS Pathogens, Vol 18, Iss 4, p e1010465 (2022)
Although efficacious vaccines have significantly reduced the morbidity and mortality of COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated by th
Externí odkaz:
https://doaj.org/article/a5a76225c38141629fe49e262e9a20b8
Autor:
Abhisek Dwivedy, Richard Mariadasse, Mohammed Ahmad, Sayan Chakraborty, Deepsikha Kar, Satish Tiwari, Sankar Bhattacharyya, Sudipta Sonar, Shailendra Mani, Prafullakumar Tailor, Tanmay Majumdar, Jeyaraman Jeyakanthan, Bichitra Kumar Biswal
Publikováno v:
PLoS Computational Biology, Vol 17, Iss 9, p e1009384 (2021)
Apart from the canonical fingers, palm and thumb domains, the RNA dependent RNA polymerases (RdRp) from the viral order Nidovirales possess two additional domains. Of these, the function of the Nidovirus RdRp associated nucleotidyl transferase domain
Externí odkaz:
https://doaj.org/article/8a0f376e1e0445a3af0361e1e121e216
Autor:
Tripti Shrivastava, Balwant Singh, Zaigham Abbas Rizvi, Rohit Verma, Sandeep Goswami, Preeti Vishwakarma, Kamini Jakhar, Sudipta Sonar, Shailendra Mani, Sankar Bhattacharyya, Amit Awasthi, Milan Surjit
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
The newly emerged novel coronavirus, SARS-CoV-2, the causative agent of COVID-19 has proven to be a threat to the human race globally, thus, vaccine development against SARS-CoV-2 is an unmet need driving mass vaccination efforts. The receptor bindin
Externí odkaz:
https://doaj.org/article/3beffa78948848c69e01f99fc7c894a5
Autor:
Sonal Garg, Nisha Raj, Asha Lukose, Deepti Jamwal, Hilal Ahmed Parray, Sandeep Kumar, Samridhi Dhyani, Kamini Jakhar, Sudipta Sonar, Mahima Tiwari, null Reema, Shailendra Mani, Sankar Bhattacharyya, Chandresh Sharma, Tripti Shrivastava, Rajesh Kumar
Publikováno v:
3 Biotech. 12
Autor:
Rajesh Kumar, Hilal Parray, Naveen Narayan, Sonal Garg, Zaigham Abbas Rizvi, Tripti Shrivastava, Sachin Kushwaha, Janmejay Singh, Praveenkumar Murugavelu, Anbalagan Anantharaj, Farha Mehdi, Nisha Raj, Shivam Singh, Jyotsna Dandotiya, Asha Lukose, Deepti Jamwal, Sandeep Kumar, Adarsh Chiranjivi, Samridhi Dhyani, Nitesh Mishra, Kamini Jakhar, Sudipta Sonar, Shirlie Chowdhury, Anil Panchal, Manas Tripathy, Shubbir Ahmed, Sweety Samal, Shailendra Mani, Sankar Bhattacharyya, Supratik Das, Subrata Sinha, Gaurav Batra, Devinder Sehgal, Guruprasad Medigeshi, Chandresh Sharma, Amit Awasthi, Pramod Garg, Deepak Nair
The emergence of new variants of SARS-CoV-2 necessitates unremitting efforts to discover novel therapeutic mAbs. Here, we report an extremely potent mAb named P4A2 that can neutralize all the circulating variants of concerns (VOCs) with high efficien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90321952534c9479c085578e48e99bd6
https://doi.org/10.21203/rs.3.rs-1431974/v1
https://doi.org/10.21203/rs.3.rs-1431974/v1
Autor:
Nitin Hingankar, Suprit Deshpande, Payel Das, Zaigham Abbas Rizvi, Alison Burns, Shawn Barman, Fangzhu Zhao, Mohammed Yousuf Ansari, Sohini Mukherjee, Jonathan L. Torres, Souvick Chattopadhyay, Farha Mehdi, Jyoti Sutar, Deepak Kumar Rathore, Kamal Pargai, Janmejay Singh, Sudipta Sonar, Kamini Jakhar, Sankar Bhattacharyya, Shailendra Mani, Savita Singh, Jyotsna Dandotiya, Pallavi Kshetrapal, Ramachandran Thiruvengadam, Gaurav Batra, Guruprasad R Medigeshi, Andrew Ward, Shinjini Bhatnagar, Amit Awasthi, Devin Sok, Jayanta Bhattacharya
Although efficacious vaccines have significantly reduced the morbidity and mortality due to COVID-19, there remains an unmet medical need for treatment options, which monoclonal antibodies (mAbs) can potentially fill. This unmet need is exacerbated b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::450862064ab351ccd4727e3e274fb0c3
https://doi.org/10.1101/2021.12.25.474152
https://doi.org/10.1101/2021.12.25.474152
Autor:
Rajat Ujjainiya, Akansha Tyagi, Viren Sardana, Salwa Naushin, Nitin Bhatheja, Kartik Kumar, Joydeb Barman, Satyartha Prakash, Rintu Kutum, Akash Kumar Bhaskar, Prateek Singh, Kumardeep Chaudhary, Menka Loomba, Yukti Khanna, Chestha Walecha, Rizwan Ahmed, Ashutosh Yadav, Archana Bajaj, Gaurav Malik, Sahar Qureshi, Swati Waghdhare, Samreen Siddiqui, Kamal Krishan Trehan, Manju Mani, Rajiv Dang, Poonam Das, Pankaj Dougall, Monica Mahajan, Sudipta Sonar, Kamini Jakhar, Reema Kumar, Mahima Tiwari, Shailendra Mani, Sankar Bhattacharyya, Sandeep Budhiraja, Anurag Agrawal, Debasis Dash, Sujeet Jha, Shantanu Sengupta
Publikováno v:
Nature communications. 13(1)
Immunization is expected to confer protection against infection and severe disease for vaccines while reducing risks to unimmunized populations by inhibiting transmission. Here, based on serial serological studies of an observational cohort of health
Autor:
Reema, Tripti Shrivastava, Sankar Bhattacharyya, Adarsh Kumar Chiranjivi, Supratik Das, Anil Kumar Panchal, S. K. Singh, Chandresh Sharma, Kalpana Luthra, Rajesh Kumar, Hilal Ahmed Parray, Vanshika Singh, Kamini Jakhar, M. Tiwari, Shailendra Mani, Murugavelu PraveenKumar, Sudipta Sonar, Deepak K. Rathore, Reshma Perween, Sweety Samal, Shubbir Ahamed
Publikováno v:
International Immunopharmacology
Cross-reactivity among the two diverse viruses is believed to originate from the concept of antibodies recognizing similar epitopes on the two viral surfaces. Cross-reactive antibody responses have been seen in previous variants of SARS and SARS-CoV-